Funding for this research was provided by:
National Institute for Health Research (Senior Investigator Award, ACF-2016-17-018, NIHR-CS-2016-16-011)
Text and Data Mining valid from 2018-04-17
Received: 5 October 2017
Accepted: 26 March 2018
First Online: 17 April 2018
Ethics approval and consent to participate
: All patients who met the eligibility criteria were consented prior to blood sampling. Ethics approval for the study was given by HRA Research Ethics Committee London (Camberwell St Giles) Address: East of England REC Centre Victoria House, Capital Park Fulbourn, Cambridge CB21 5XB. Approval reference: 12/LO/0326.
: MS is on the steering committee for a clinical trial of anti PD-L1 therapy in sepsis. The other authors have no competing interests to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.